Home/Stellular Bio/Philip R. Reilly
PR

Philip R. Reilly

Chief Medical Officer

Stellular Bio

Stellular Bio Pipeline

DrugIndicationPhase
STLR-201Sjogren's syndrome-related dry eye diseasePre-clinical